| |
|
|
|
Cleveland BioLabs Inc.  
|
|
0.68 -0.17 (-0.2%) |
10-16 15:58 |
|
Open: |
0.85 |
Pre close: |
0.85 |
Target:
|
1.25 
|
|
High: |
0.85 |
Low: |
0.6704 |
Resistance:
|
1.07
1.32
|
|
Volume: |
64,072 |
Market Cap: |
8M |
Support:
|
0.67
0.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.90
|
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
1.00 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
1.35 |
Stochastic Oscillator |
%K(14,3):
|
3.46 |
|
MA(250): |
1.48 |
%D(3): |
3.08  |
|
Average Volume(K) |
3-Month: |
1150
|
52-Week |
High:
|
2.16 |
|
10-Days: |
1559 |
Low: |
0.67 |
|
RSI |
RSI(14):
|
16.80 |
Change(%): |
-60.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.268 |
Return on Equity (ttm) |
-83.8 |
Shares Out. (M) |
11.30 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-42.6 |
Shares Float (M) |
4.73 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
58.14 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-29.3 |
% Held by Institutions |
5.41 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
-0.219 |
Shares Short (K) |
24 |
|
Book Value (p.s.) |
-0.260 |
EBITDA (p.s.) |
-0.304 |
P/E |
-2.54 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.62 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-3.92 |
P/S |
85377784.00 |
|
Operating Margin |
-347.87 |
Levered Free Cash Flow
(M) |
-2.96 |
P/CF |
-1.96 |
|
|
|
|
|
|
